Thai Red Cross AIDS Research Centre
Welcome,         Profile    Billing    Logout  
 31 Trials 
15 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ruxrungtham, Kiat
RV582, NCT05769569: Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission

Withdrawn
1
35
RoW
VRC07-523LS, VRC-HIVMAB075-00-AB, PGDM1400LS, N-803, Ad26.Mos4.HIV, MVA-BN-HIV, A244d11 gp120, ALFQ, Antiretroviral Therapy (ART)
Henry M. Jackson Foundation for the Advancement of Military Medicine, US Military HIV Research Program, Janssen Vaccines & Prevention B.V.
HIV-1-infection
07/25
07/25
Avihingsanon, Anchalee
STOMP, NCT05534984: Study of Tecovirimat for Human Mpox Virus

Active, not recruiting
3
719
Japan, US, RoW
Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label)
National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies
MPOX
10/24
09/25
NCT05343481: Efficacy of VTP-300 in Chronic Hepatitis B Infection

Active, not recruiting
2
120
RoW
ChAdOx1-HBV, MVA-HBV, Nivolumab, Opdivo 10mg/ml concentrate for solution for infusion
Barinthus Biotherapeutics
Chronic Hepatitis B
02/25
10/26
NCT05330455: Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

Recruiting
2
132
Europe, Canada, RoW
GSK3965193, Placebo to match GSK3965193, Bepirovirsen
GlaxoSmithKline
Hepatitis B
10/27
10/27
NCT05276297 / 2021-003567-10: A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy

Active, not recruiting
2
184
Europe, RoW
GSK3228836, Bepirovirsen, GSK3528869A, Control
GlaxoSmithKline, GlaxoSmithKline Biologicals
Hepatitis B, Chronic
02/26
02/26
B-Sure, NCT04954859 / 2021-000554-26: Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants

Recruiting
2
450
Europe, Canada, Japan, US, RoW
Bepirovirsen, Placebo
GlaxoSmithKline, GlaxoSmithKline Research & Development Limited
Hepatitis B
02/29
02/29
NCT03866187 / 2017-001452-55: Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Terminated
1/2
135
Europe, RoW
ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo
GlaxoSmithKline, GlaxoSmithKline Biologicals
Hepatitis B, Chronic
10/24
10/24
NCT05350865: Thailand HDV Cohort

Recruiting
N/A
3152
RoW
The HIV Netherlands Australia Thailand Research Collaboration, King Chulalongkorn Memorial Hospital, Thai Red Cross AIDS Research Centre, Siriraj Hospital, Taksin Hospital, Gilead Sciences
HDV
05/25
05/25
Chomchey, Nitiya -
AAHIV, NCT00796263: Antiretroviral Therapy for Acute and Chronic HIV Infection

Recruiting
3
722
RoW
HAART, Kivexa, Tivicay
South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare
Acute HIV Infection, Chronic HIV Infection
06/33
06/33
Phanuphak, Nittaya
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
06/28
06/28
NCT03194880: Alere COMBO and Alere q Detect in an HIV PrEP Program in Thailand

Completed
N/A
150
RoW
AlereCOMBO and Alere q Detect
Thai Red Cross AIDS Research Centre, Alere, Inc.
HIV
12/22
02/23
Phanuphak, Praphan
AAHIV, NCT00796263: Antiretroviral Therapy for Acute and Chronic HIV Infection

Recruiting
3
722
RoW
HAART, Kivexa, Tivicay
South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare
Acute HIV Infection, Chronic HIV Infection
06/33
06/33
BHVD, NCT01634607: Bone Health and Vitamin D Status

Completed
N/A
235
RoW
Thai Red Cross AIDS Research Centre, ViiV Healthcare, HIV Netherlands Australia Thailand Research Collaboration, Bamrasnaradura Infectious Diseases Institute, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Osteopenia, Vitamin D Deficiency, HIV Infection
07/21
02/23
Suttichom, Duanghathai
AAHIV, NCT00796263: Antiretroviral Therapy for Acute and Chronic HIV Infection

Recruiting
3
722
RoW
HAART, Kivexa, Tivicay
South East Asia Research Collaboration with Hawaii, Thai Red Cross AIDS Research Centre, Pfizer, Gilead Sciences, Merck Sharp & Dohme LLC, ViiV Healthcare
Acute HIV Infection, Chronic HIV Infection
06/33
06/33
Vasan, Sandhya
NCT04826094: A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Completed
1
126
RoW
Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®, ALF43, dmLT, Placebo (IM), Placebo (TCl)
National Institute of Allergy and Infectious Diseases (NIAID), US Army Medical Research Directorate-Africa, US Military HIV Research Program, The Emmes Company, LLC, Walter Reed Army Institute of Research (WRAIR)
HIV Infections
02/24
02/24
Trautmann, Lydie
No trials found

Download Options